Treating Attention-Deficit/Hyperactivity Disorder Matters

FR Levin, M Hernandez, JJ Mariani - JAMA, 2024 - jamanetwork.com
In this issue of JAMA, Li and colleagues1 used an observational target trial emulation
analysis to investigate whether attention-deficit/hyperactivity disorder (ADHD) medication …

Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea

Y Cho, AY Kim, S Lee, H Lee - International Clinical …, 2024 - journals.lww.com
The prevalence of attention-deficit/hyperactivity disorder (ADHD) is steadily increasing
across Korea. We analyzed ADHD patients with ADHD medications (Rx) characteristics and …

Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study

JD Thornton, T Varisco, H Patel, M Shrestha… - BMJ open, 2024 - bmjopen.bmj.com
Objective To evaluate co-prescribing of sedatives hypnotics and opioids. Design
Retrospective study evaluating the association of patient characteristics and comorbidities …

The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism: An interrupted time-series analysis in …

C Cunningham, O Macdonald, AL Schaffer, AD Brown… - medRxiv, 2024 - medrxiv.org
Background COVID-19 lockdowns led to increased reports of depressive symptoms in the
general population and impacted the health and social care services of people with learning …